Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials

PURPOSE: The impact of a personalized cancer treatment strategy (ie, matching patients with drugs based on specific biomarkers) is still a matter of debate. METHODS: We reviewed phase II single-agent studies (570 studies; 32,149 patients) published between January 1, 2010, and December 31, 2012 (Pub...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Oncol
Auteurs principaux: Schwaederle, Maria, Zhao, Melissa, Lee, J. Jack, Eggermont, Alexander M., Schilsky, Richard L., Mendelsohn, John, Lazar, Vladimir, Kurzrock, Razelle
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2015
Sujets:
Review Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4737863/
https://ncbi.nlm.nih.gov/pubmed/26304871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.61.5997
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires